Roger D Norcross Selected Research

(4- chlorophenyl)- (1H- imidazol- 4- ylmethyl)- isopropyl- amine

8/2012

Optimisation of imidazole compounds as selective TAAR1 agonists: discovery of RO5073012.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roger D Norcross Research Topics

Disease

4	Schizophrenia (Dementia Praecox) 02/2015 - 06/2010
1	Mental Disorders (Mental Disorder) 02/2016
1	Obesity 01/2016
1	Insulin Resistance 01/2016
1	Body Weight (Weight, Body) 01/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Central Nervous System Diseases (CNS Diseases) 12/2012
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2009
1	Neoplasms (Cancer) 11/2001

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 02/2016 - 11/2009
1	Trace amine-associated receptor 1IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Triglycerides (Triacylglycerol)IBA 01/2016
1	4- (3- fluoro- 2- methylphenyl)- 4,5- dihydrooxazol- 2- ylamineIBA 02/2015
1	4- (3,4- dichlorophenyl)- 4,5- dihydrooxazol- 2- ylamineIBA 12/2012
1	TyramineIBA 11/2012
1	AminesIBA 11/2012
1	tryptamineIBA 11/2012
1	Biogenic Amines (Biogenic Amine)IBA 11/2012
1	(4- chlorophenyl)- (1H- imidazol- 4- ylmethyl)- isopropyl- amineIBA 08/2012
1	(4- (3- fluoro- 5- trifluoromethylpyridin- 2- yl)piperazin- 1- yl)(5- methanesulfonyl- 2- (2,2,2- trifluoro- 1- methylethoxy)phenyl)methanoneIBA 06/2010
1	MacrolidesIBA 11/2001
1	Antimitotic AgentsIBA 11/2001
1	spongistatin 1IBA 11/2001

Therapy/Procedure

1	Therapeutics 01/2016
1	Drug Therapy (Chemotherapy) 11/2001